此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Efficacy of Cancer Support Programs: A Social Comparison Theory Analysis

2019年5月13日 更新者:M.D. Anderson Cancer Center
The goal of this research study is to learn if a support group program is acceptable for patients with prostate cancer or patients with breast cancer. Researchers also want to learn if the characteristics of the members of the support group program can have an effect on the quality of life of other members of the support group program. Support group programs will be conducted separately for prostate cancer patients and breast cancer patients.

研究概览

详细说明

Screening Questionnaires:

Signing this consent form does not mean that you will be able to take part in this study. You will complete some questions about your mood to help researchers decide if you are eligible to take part in this study. It will take 10 to 15 minutes to complete these questions.

The researcher will discuss the questionnaire results with you and provide you with a list of community referrals and resources.

If your responses to the questions show that you are distressed, you will be eligible to take part in this study. If your responses to the questions show that you are not distressed, you will be randomly selected (as in the flip of a coin) to take part in this study.

If your responses to the questions show that you may harm yourself, a licensed psychologist will follow-up with you and make recommendations for future treatment.

Study Questionnaires:

If you are found to be eligible and are selected to take part in this study, you will be asked to complete questionnaires that will have questions about your medical history, quality of life, mood, thought processes, methods of coping with the disease, and support that you receive from others. It will take about 1 hour to complete these questionnaires.

Support Groups:

You will also take part in a support group program for either prostate or breast cancer patients. Each support group will be made up of about 10 members. Each group will meet 1 time each week for 10 weeks. Each meeting will last about 2 hours. At each meeting, patients will discuss and learn about methods of coping with the disease and ways to relax.

All meetings will be audio-recorded. Recordings will be reviewed by the research team to make sure that the groups are covering the program content.

Length of Study:

You will be on study for about 3 months.

End-of Study Questionnaires:

After the last support group meeting, you will complete questionnaires that will ask questions about your medical history, quality of life, mood, thought processes, methods of coping with the disease, and support that you receive from others. You will be off study after you have completed the end-of-study questionnaires.

This is an investigational study.

Up to 240 patients will take part in this study. Up to 204 will be enrolled at MD Anderson.

研究类型

观察性的

注册 (预期的)

240

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Texas
      • Houston、Texas、美国、77030
        • University of Texas MD Anderson Cancer Center

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

21年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

取样方法

概率样本

研究人群

Participants, 21 years of age or older, diagnosed with Prostate Cancer or Breast Cancer.

描述

Inclusion Criteria:

  1. Diagnosis of prostate or breast cancer, regardless of treatment
  2. No evidence of metastatic disease
  3. Able to read, speak, and write English
  4. Resides within one hour of M.D. Anderson Cancer Center
  5. 21 years of age or older
  6. Able to provide meaningful informed consent as judged by a research team member
  7. Being a distressed patient: a T score greater than or equal to 63 on the Global Severity Index (GSI) of the Brief Symptom Inventory (BSI) or a T score greater than or equal to 63 on any two primary dimensions of this measure, or being a non-distressed patient: a T score of < 63 on the GSI and a T score of <63 on all primary dimensions of the BSI.

Exclusion Criteria:

1) None

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
干预/治疗
Homogeneous Support Group
10 weekly group meetings lasting 2 hours.
Surveys
Heterogeneous Support Group One
10 weekly group meetings lasting 2 hours.
Surveys
Heterogeneous Support Group Two
10 weekly group meetings lasting 2 hours.
Surveys

研究衡量的是什么?

主要结果指标

结果测量
大体时间
Patient Psychological Functioning and Quality of Life (QOL)
大体时间:Baseline and Month 3: Questionnaires & Support Group Assessments
Baseline and Month 3: Questionnaires & Support Group Assessments

次要结果测量

结果测量
大体时间
To study if the characteristics of the members of the support group program can have an effect on the quality of life of other members of the support group program.
大体时间:2 Years
2 Years

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Cindy L Carmack Taylor, PHD、M.D. Anderson Cancer Center

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2009年5月1日

初级完成 (实际的)

2019年3月26日

研究完成 (实际的)

2019年3月26日

研究注册日期

首次提交

2008年11月24日

首先提交符合 QC 标准的

2008年11月25日

首次发布 (估计)

2008年11月26日

研究记录更新

最后更新发布 (实际的)

2019年5月15日

上次提交的符合 QC 标准的更新

2019年5月13日

最后验证

2019年5月1日

更多信息

与本研究相关的术语

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Group Meetings的临床试验

3
订阅